Back to Search Start Over

The Reality of Randomized Controlled Trials for Assessing the Benefit of Proton Therapy: Critically Examining the Intent-to-Treat Principle in the Presence of Insurance Denial

Authors :
Mike Hernandez, MS
J. Jack Lee, PhD
Beow Y. Yeap, ScD
Rong Ye, MS
Robert L. Foote, MD
Paul Busse, MD, PhD
Samir H. Patel, MD
Roi Dagan, MD
James Snider, MD
Nasiruddin Mohammed, MD, MBA
Alexander Lin, MD
Pierre Blanchard, MD, PhD
Scott B. Cantor, PhD
Menna Y. Teferra, MS
Kate Hutcheson, PhD
Pablo Yepes, PhD
Radhe Mohan, PhD
Zhongxing Liao, MD
Thomas F. DeLaney, MD
Steven J. Frank, MD
Source :
Advances in Radiation Oncology, Vol 6, Iss 2, Pp 100635- (2021)
Publication Year :
2021
Publisher :
Elsevier, 2021.

Abstract

Purpose: This study hypothesized that insurance denial would lead to bias and loss of statistical power when evaluating the results from an intent-to-treat (ITT), per-protocol, and as-treated analyses using a simulated randomized clinical trial comparing proton therapy to intensity modulated radiation therapy where patients incurred increasing rates of insurance denial. Methods and Materials: Simulations used a binary endpoint to assess differences between treatment arms after applying ITT, per-protocol, and as-treated analyses. Two scenarios were developed: 1 with clinical success independent of age and another assuming dependence on age. Insurance denial was assumed possible for patients

Details

Language :
English
ISSN :
24521094
Volume :
6
Issue :
2
Database :
Directory of Open Access Journals
Journal :
Advances in Radiation Oncology
Publication Type :
Academic Journal
Accession number :
edsdoj.b12c4a70c7db456e8bdeb25effe791bb
Document Type :
article
Full Text :
https://doi.org/10.1016/j.adro.2020.100635